Correction: A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdenosine and Purinergic Signaling · Cancer Immunotherapy and Biomarkers · Advanced Breast Cancer Therapies
Tay AHM, Prieto-Díaz R, Neo S, et al. A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models. J Immunother Cancer 2022; 10: e004592. doi: 10.1136/jitc-2022-004592.
In this article The x-axis on figures 4B, D, F and G have been updated to include the correct values.